AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

PODD · NASDAQ · Medical - Devices

Insulet (PODD)

Builds tubeless Omnipod insulin-delivery systems with automated dosing and glucose-sensor integration.

$138.05

After hours−1.32 (−0.95%)

At close$139.37(−0.83%)

In millions of USD, except per-share figures

In millions	Q3 FY23Sep 2023	Q4 FY23Dec 2023	Q1 FY24Mar 2024	Q2 FY24Jun 2024	Q3 FY24Sep 2024	Q4 FY24Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Revenue	433	510	442	489	544	598	569	649	706	784	762	802
Cost of revenue	139	149	135	158	167	167	160	197	196	215	233	239
Gross profit	293	361	307	331	377	431	409	452	510	569	529	563
	239	255	250	276	289	322	320	331	392	422	407	433
Research & development	58	42	50	54	55	61	60	73	77	91	90	88
	181	213	200	223	234	261	261	258	315	331	317	345
Selling & marketing	0	0	0	0	0	24	0	0	0	0	0	0
General & administrative	0	0	0	0	0	237	0	0	0	0	0	0
Operating income	55	106	57	55	88	109	89	121	118	146	122	130
	−1	1	−2	−3	−5	2	−41	−93	5	−6	−9	−11
Interest income	9	6	9	9	11	10	10	10	9	6	5	4
Interest expense	10	7	11	11	12	9	9	20	16	20	15	14
Other non-operating income	−9	−8	−9	−8	−7	−11	32	73	−21	−14	−6	−3
Income before tax	54	108	55	51	83	111	48	28	123	140	113	119
Income tax expense	2	5	3	−138	5	11	13	6	35	39	22	24
Net income from continuing operations	52	103	52	189	78	101	35	23	88	102	91	95
Net income	52	103	52	189	78	101	35	23	88	102	91	95
EPS, basic	$0.74	$1.48	$0.74	$2.69	$1.11	$1.44	$0.50	$0.32	$1.24	$1.45	$1.30	$1.37
EPS, diluted	$0.70	$1.48	$0.73	$2.59	$1.08	$1.39	$0.50	$0.32	$1.24	$1.44	$1.30	$1.37
Weighted average shares, basic	70	70	70	70	70	70	70	70	71	70	70	69
Weighted average shares, diluted	74	70	74	74	74	74	74	71	71	71	70	69
EBITDA	83	133	84	81	117	142	79	70	160	190	154	132
Depreciation & amortization	19	19	19	19	21	22	22	22	22	31	26	0
EBIT	64	115	66	62	95	120	57	48	138	160	128	132